| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |

From the Department of Laboratory Medicine and Pathology* and the University of Minnesota Cancer Center,
University of Minnesota, Minneapolis, Minnesota
Hyaluronan (HA), a secreted glycosaminoglycan component of extracellular matrices, is critical for cellular proliferation and motility during development. However, elevated circulating and cell-associated levels correlate with various types of cancer, including prostate. We have previously shown that aggressive PC3M-LN4 prostate tumor cells synthesize excessive HA relative to less aggressive cells, and express correspondingly higher levels of the HA biosynthetic enzymes HAS2 and HAS3. Inhibition of these enzymes by stable transfection of PC3M-LN4 cells with anti-sense HAS2 or HAS3 expression constructs diminishes HA synthesis and surface retention. In this report, we used these HA-deficient cell lines to examine the role of HA in tumorigenicity. Subcutaneous injection of SCID mice with hyaluronan synthase (HAS) antisense-transfected cells produced tumors threefold to fourfold smaller than control transfectants. Tumors from HAS antisense transfectants were histologically HA-deficient relative to controls. HA deficiency corresponded to threefold reduced cell numbers per tumor, but comparable numbers of apoptotic and proliferative cells. Percentages of apoptotic cells in cultured transfectants were identical to those of control cells, but antisense inhibition of HA synthesis effected slower growth rate of cells in culture. Quantification of blood vessel density within tumor sections revealed 70 to 80% diminished vascularity of HAS antisense tumors. Collectively, the results suggest HAS overexpression by prostate tumor cells may facilitate their growth and proliferation in a complex environment by enhancing intrinsic cell growth rates and promoting angiogenesis. Furthermore, this is the first report of a role for inhibition of HA synthesis in reducing tumor growth kinetics.
This article has been cited by other articles:
![]() |
S. Kim, N. Kim, B. Dong, D. Boren, S. A. Lee, J. Das Gupta, C. Gaughan, E. A. Klein, C. Lee, R. H. Silverman, et al. Integration Site Preference of Xenotropic Murine Leukemia Virus-Related Virus, a New Human Retrovirus Associated with Prostate Cancer J. Virol., October 15, 2008; 82(20): 9964 - 9977. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Goel, J. Li, S. Kogan, and L. R Languino Integrins in prostate cancer progression Endocr. Relat. Cancer, September 1, 2008; 15(3): 657 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ganesh, M. Gonzalez-Edick, D. Gibbons, M. Van Roey, and K. Jooss Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models Clin. Cancer Res., June 15, 2008; 14(12): 3933 - 3941. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Jokela, M. Jauhiainen, S. Auriola, M. Kauhanen, R. Tiihonen, M. I. Tammi, and R. H. Tammi Mannose Inhibits Hyaluronan Synthesis by Down-regulation of the Cellular Pool of UDP-N-acetylhexosamines J. Biol. Chem., March 21, 2008; 283(12): 7666 - 7673. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Golshani, L. Lopez, V. Estrella, M. Kramer, N. Iida, and V. B. Lokeshwar Hyaluronic Acid Synthase-1 Expression Regulates Bladder Cancer Growth, Invasion, and Angiogenesis through CD44 Cancer Res., January 15, 2008; 68(2): 483 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bharadwaj, K. Rector, and M. A. Simpson Inducible Hyaluronan Production Reveals Differential Effects on Prostate Tumor Cell Growth and Tumor Angiogenesis J. Biol. Chem., July 13, 2007; 282(28): 20561 - 20572. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Kovar, M. A. Johnson, W. M. Volcheck, J. Chen, and M. A. Simpson Hyaluronidase Expression Induces Prostate Tumor Metastasis in an Orthotopic Mouse Model Am. J. Pathol., October 1, 2006; 169(4): 1415 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Simpson Concurrent Expression of Hyaluronan Biosynthetic and Processing Enzymes Promotes Growth and Vascularization of Prostate Tumors in Mice Am. J. Pathol., July 1, 2006; 169(1): 247 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tzircotis, R. F. Thorne, and C. M. Isacke Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding J. Cell Sci., November 1, 2005; 118(21): 5119 - 5128. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Udabage, G. R. Brownlee, M. Waltham, T. Blick, E. C. Walker, P. Heldin, S. K. Nilsson, E. W. Thompson, and T. J. Brown Antisense-Mediated Suppression of Hyaluronan Synthase 2 Inhibits the Tumorigenesis and Progression of Breast Cancer Cancer Res., July 15, 2005; 65(14): 6139 - 6150. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zareie, A. S. De Vriese, L. H. P. Hekking, P. M. ter Wee, C. G. Schalkwijk, B. A. J. Driesprong, I. L. Schadee-Eestermans, R. H. J. Beelen, N. Lameire, and J. van den Born Immunopathological changes in a uraemic rat model for peritoneal dialysis Nephrol. Dial. Transplant., July 1, 2005; 20(7): 1350 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Lokeshwar, W. H. Cerwinka, and B. L. Lokeshwar HYAL1 Hyaluronidase: A Molecular Determinant of Bladder Tumor Growth and Invasion Cancer Res., March 15, 2005; 65(6): 2243 - 2250. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Peehl Primary cell cultures as models of prostate cancer development Endocr. Relat. Cancer, March 1, 2005; 12(1): 19 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Kim, M. A. Wheeler, C. M. Wilson, J. Iida, D. Eng, M. A. Simpson, J. B. McCarthy, and K. M. Bullard Hyaluronan Facilitates Invasion of Colon Carcinoma Cells in Vitro via Interaction with CD44 Cancer Res., July 1, 2004; 64(13): 4569 - 4576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. ROGERS, R. M. ROHAN, A. E. BIRSNER, and R. J. D'AMATO Genetic loci that control the angiogenic response to basic fibroblast growth factor FASEB J, July 1, 2004; 18(10): 1050 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Sommer, J. J. Barycki, and M. A. Simpson Characterization of Human UDP-glucose Dehydrogenase: CYS-276 IS REQUIRED FOR THE SECOND OF TWO SUCCESSIVE OXIDATIONS J. Biol. Chem., May 28, 2004; 279(22): 23590 - 23596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Monslow, J. D. Williams, C. A. Guy, I. K. Price, K. J. Craig, H. J. Williams, N. M. Williams, J. Martin, S. L. Coleman, N. Topley, et al. Identification and Analysis of the Promoter Region of the Human Hyaluronan Synthase 2 Gene J. Biol. Chem., May 14, 2004; 279(20): 20576 - 20581. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Itano, T. Sawai, F. Atsumi, O. Miyaishi, S. Taniguchi, R. Kannagi, M. Hamaguchi, and K. Kimata Selective Expression and Functional Characteristics of Three Mammalian Hyaluronan Synthases in Oncogenic Malignant Transformation J. Biol. Chem., April 30, 2004; 279(18): 18679 - 18687. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zareie, L. H. P. Hekking, A. G. A. Welten, B. A. J. Driesprong, I. L. Schadee-Eestermans, D. Faict, A. Leyssens, C. G. Schalkwijk, R. H. J. Beelen, P. M. ter Wee, et al. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2629 - 2637. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zoltan-Jones, L. Huang, S. Ghatak, and B. P. Toole Elevated Hyaluronan Production Induces Mesenchymal and Transformed Properties in Epithelial Cells J. Biol. Chem., November 14, 2003; 278(46): 45801 - 45810. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Desrivieres, T. Prinz, N. Castro-Palomino Laria, M. Meyer, G. Boehm, U. Bauer, J. Schafer, T. Neumann, C. Shemanko, and B. Groner Comparative Proteomic Analysis of Proliferating and Functionally Differentiated Mammary Epithelial Cells Mol. Cell. Proteomics, October 1, 2003; 2(10): 1039 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Toole and V. C. Hascall Hyaluronan and Tumor Growth Am. J. Pathol., September 1, 2002; 161(3): 745 - 747. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |